Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Placebo-Controlled, Double-Blind Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

NCT01609140 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01609140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Placebo-Controlled, Double-Blind Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
July 31, 2013
Enrollment
248 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease